Dr Reddy’s has announced the launch of the first US generic version of Vimovo (naproxen/esomeprazole) delayed-release tablets in 375mg/20mg and 500mg/20mg strengths, in bottles of 60 tablets. However, Nuvo Pharmaceuticals – which licenses the product to Horizon Pharma for marketing in the US – has warned that the at-risk launch infringes patents protecting the arthritis treatment until May 2022.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?